Ann: Market Rumours, page-64

- The stock has returned 80% since the lows of late 2015;
- the business is not enduring any mass exodus, it faces a much friendlier budgetary environment where up until recently many on this site were convinced Medicare rebates would never be re-indexed
- it retains an oligopolistic participation in pathology
- it is enjoying strong growth in radiology
- it will experience its highest recruitment in registrars
- it has changed its GP remuneration model, impacting near term earnings yet making this division of business more sustainable
- it is generating more free cashflow from its Medical Centres despite lower EBIT, also being impacted by accelerated amortization costs (hopefully you can understand what I am saying here)
- it is opening several new Centres that will underpin profit growth in future fears and continues to invest some half its capex in growth projects
- it has appointed a new CEO that has received widespread applause
- it has net debt under control, some $300m less than 2 years ago
- it has a keen significant shareholder waiting in the wings, that apparently is presently having issues in getting its funds out of its homeland

You landed on this site full of vitriol against the company, only to reveal you were formally employed and now working at the publicly funded ATSIC.

You now claim to be informing of ongoing unsubstantiated internal 'leaks' that the public should be aware of.

You are not an investor in PRY.

I suggest you reconsider your approach to vilification here.